Globe Life (NYSE:GL) Announces FY 2026 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2026 earnings guidance on Friday morning. The company provided earnings per share guidance of 15.350-15.650 for the period, compared to the consensus EPS estimate of 15.720. Globe Life also updated its FY 2027 guidance to 16.100-17.100 EPS.

Analysts Set New Price Targets

GL has been the topic of several analyst reports. Keefe, Bruyette & Woods lowered their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday. TD Cowen reduced their price objective on shares of Globe Life from $225.00 to $215.00 and set a “buy” rating for the company in a research report on Friday. Jefferies Financial Group lifted their price objective on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Finally, Morgan Stanley lowered their price objective on Globe Life from $208.00 to $197.00 and set an “overweight” rating on the stock in a report on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $182.60.

Globe Life Trading Down 8.2%

NYSE:GL opened at $154.62 on Friday. The company has a market capitalization of $11.88 billion, a PE ratio of 10.34 and a beta of 0.44. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life has a 52-week low of $127.85 and a 52-week high of $191.55. The stock has a fifty day simple moving average of $169.95 and a 200-day simple moving average of $167.16.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, October 21st. The company reported $4.84 earnings per share for the quarter, missing analysts’ consensus estimates of $4.90 by ($0.06). The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the business earned $4.81 earnings per share. On average, equities research analysts expect that Globe Life will post 15.61 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio (DPR) is currently 8.83%.

Globe Life declared that its board has approved a share buyback program on Monday, August 10th that permits the company to repurchase $2.50 billion in shares. This repurchase authorization permits the company to purchase up to 17.7% of its shares through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its stock is undervalued.

Insider Transactions at Globe Life

In other news, EVP Robert Hensley sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total value of $1,700,700.00. Following the completion of the sale, the executive vice president directly owned 12,384 shares in the company, valued at approximately $2,106,146.88. The trade was a 44.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Thomas Kalmbach sold 25,650 shares of Globe Life stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the completion of the transaction, the chief financial officer directly owned 50,568 shares of the company’s stock, valued at approximately $9,030,433.44. This represents a 33.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 143,650 shares of company stock worth $25,793,717 in the last quarter. Insiders own 2.11% of the company’s stock.

Key Headlines Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life projected 2027 adjusted earnings of $16.10–$17.10 per share, with the midpoint modestly above the current consensus estimate of $16.51. Management also targeted $850 million–$950 million in parent excess cash flow, supporting potential capital returns. Globe Life projects 2027 EPS and excess cash flow
• Positive Sentiment: TD Cowen maintained a Buy rating, although it reduced its price target from $225 to $215. The revised target still implies substantial potential upside based on the referenced share price. TD Cowen price target update
• Neutral Sentiment: Management’s 2027 EPS guidance range spans $16.10–$17.10, indicating continued growth potential but also a relatively wide range of outcomes. The company’s quarterly revenue and investment income benefited from growth in premiums and investments. Globe Life earnings guidance
• Negative Sentiment: Globe Life reported third-quarter EPS of $4.84, below analyst expectations near $4.87–$4.90. Weaker underwriting income, rising expenses and a reported $6.4 million underwriting loss offset higher premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life lowered its 2026 EPS guidance to $15.35–$15.65, below the $15.72 consensus estimate. The weaker outlook was linked in part to losses at Evry Health, increasing concerns about profitability and execution. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded Globe Life, arguing that the stock is no longer a “predictable safe haven” following the earnings release. The downgrade adds pressure to investor sentiment after the earnings miss and guidance reduction. Piper Sandler downgrades Globe Life

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.